GlassScriptPhysician profile
Renata E Robertson
NPI 1740646348
$2,812.24
in general payments reported to CMS, 2019-2025
40 companies · $847 in 2025
The $847 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2022: $405 · 2023: $720 · 2024: $567 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785 · Education: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.88 |
| Education | $348.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $324.02 | 2022-2025 | Opdivo |
| Janssen Biotech, INC. | $282.91 | 2022-2025 | Rybrevant, Carvykti, Erleada |
| Abbvie INC. | $276.76 | 2022-2025 | |
| Genentech USA, INC. | $201.54 | 2022-2025 | Polivy, Tecentriq, Alecensa |
| Seagen INC. | $184.72 | 2023 | Padcev |
| Astrazeneca Pharmaceuticals LP | $164.05 | 2021-2025 | Onglyza, Enhertu, Calquence |
| Amgen INC. | $124.12 | 2022 | |
| Genzyme Corporation | $103.57 | 2022-2024 | |
| Janssen Products, LP | $99.95 | 2021 | |
| Gilead Sciences, INC. | $94.00 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $87.22 | 2022-2024 | Libtayo |
| Sanofi-Aventis U.S. LLC | $84.99 | 2023 | |
| Celgene Corporation | $81.16 | 2023-2024 | Reblozyl, Pomalyst, Opdualag |
| Novartis Pharmaceuticals Corporation | $77.10 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $40.68 | 2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.